Wed, 09th Sep 2020 00:47
BRASILIA, Sept 8 (Reuters) - Brazil health regulator Anvisa
said on Tuesday that AstraZeneca PLC had announced the
suspension of global trials for a coronavirus vaccine, which
included a human trial being done in Brazil.
AstraZeneca had directly informed Anvisa about the
suspension, the regulator said, adding that it is waiting for
further details on the reason trials were stopped.
(Reporting by Ricardo Brito; writing by Jake Spring; Editing by
Sandra Maler)
(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of Engla...
FTSE 100 up 0.5%, FTSE 250 adds 0.4% *
(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the...
(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:
Astrazeneca (AZN)